Company Filing History:
1 out of 296 
1 out of 832,912 Years Active: 2015-2022
Title: Michael Sebag: Innovator in Cancer Research
Introduction
Michael Sebag is a prominent inventor based in Montreal, Canada. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 2 patents, his work focuses on developing novel compounds and methods that have the potential to improve cancer treatment.
Latest Patents
One of Michael Sebag's latest patents is titled "Substituted bicyclic pyrimidine-based compounds and compositions and uses thereof." This patent describes novel C-2-substituted bicyclic compounds that have been found to be effective as inhibitors by inhibiting geranylgeranylation of proteins. The application is directed towards these compounds, their compositions, and their use as medicaments for cancer and other conditions treatable by inhibiting human geranylgeranylation pyrophosphate hGGPPS activity.
Another significant patent is "Method of obtaining circulating cancer cell populations." This patent provides methods for obtaining circulating cancer cells (CCCs)-enriched cellular populations by removing CD45-positive cells from an apheresis product. It also outlines methods for obtaining circulating stem cells (CSCs)-enriched cellular populations and circulating tumor cells (CTCs)-enriched cellular populations based on specific cellular markers. Additionally, it includes screening assays for selecting (chemo)therapeutic agents and personalized medicine applications based on drug sensitivity/resistance or cancer markers.
Career Highlights
Throughout his career, Michael Sebag has worked with notable institutions, including The Royal Institution for the Advancement of Learning/McGill University. His research has focused on innovative solutions to combat cancer, showcasing his dedication to advancing medical science.
Collaborations
Michael has collaborated with esteemed colleagues such as Youla S Tsantrizos and Catalin Mihalcioiu. These partnerships have contributed to the development of his groundbreaking patents and research initiatives.
Conclusion
Michael Sebag is a distinguished inventor whose work in cancer research has led to the development of innovative patents that hold promise for improving treatment options. His contributions to the field are invaluable and reflect his commitment to advancing healthcare solutions.